Does a patient with hereditary spherocytosis qualify for preoperative autologous blood donation?

Transfusion

Volumn 37, Issue 11-12, 1997, Pages 1179-1183

  Weinstein, R ^a   Martinez, R ^a,b   Hassoun, H ^a,b   Palek, J ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Elizabeth's Medical Center of Boston

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CASE REPORT; ERYTHROCYTE FRAGILITY; ERYTHROCYTE TRANSFUSION; HEMOLYSIS; HEREDITARY SPHEROCYTOSIS; HUMAN; HUMAN CELL; MALE; PREOPERATIVE PERIOD; SPLENOMEGALY;

EID: 0031446862     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37111298088049.x     Document Type: Article

References (34)

1. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood. Transfusion alert: use of autologous blood. Transfusion 1995;35:703-11.
2. Klein HG, ed. Standards for blood banks and transfusion services. 17th ed. Bethesda: American Association of Blood Banks, 1996.
3. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
4. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995;35:734-7.
5. Morton NE, MacKinney AA, Kosower N, et al. Genetics of spherocytosis. Am J Hum Genet 1962;14:170-84.
6. Godal HC, Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol 1981;27:30-4.
7. Eber SW, Pekrun A, Neufeldt A, Schröter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol 1992;64:88-92.
8. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 1993;30:249-83.
9. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev 1996;10:129-47.
10. Emerson CP Jr, Shen SC, Ham TH, et al. The mechanism of blood destruction in congenital hemolytic jaundice. J Clin Invest 1947;26:1180-90.
11. Haradin AR, Weed RI, Reed CF. Changes in physical properties of stored erythrocytes. Relationship to survival in vivo. Transfusion 1969;9:229-37.
12. Stoltz JF, Vigneron C, Streiff F. Alterations of red blood cell osmotic fragility during storage of blood drawn on ACD solution. Vox Sang 1971;21:86-9.
13. Beutler E, Kuhl W, West C. The osmotic fragility of erythrocytes after prolonged liquid storage and after reinfusion. Blood 1982;59:1141-7.
14. Beutler E, West C. Storage of red cell concentrates in CPD-A2 for 42 and 49 days. J Lab Clin Med 1983;102:53-62.
15. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate-phosphate-dextrose-adenine-1. Vox Sang 1984;47:261-70.
16. Moroff G, Morse EE, Katz AJ, et al. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24°C for eight hours following phlebotomy. Transfusion 1984;24:115-9.
17. Heaton A, Miripol J, Aster R, et al. Use of Adsol preservation solution for prolonged storage of low viscosity AS-1 red blood cells. Br J Haematol 1984;57:467-78.
18. 51Cr. Analysis of validity. Transfusion 1984;24:100-4.
19. 51Chromium post-transfusion recovery of red cells stored in saline, adenine, glucose, mannitol for 42 days. Vox Sang 1989;57:37-42.
20. 5ICr posttransfusion recovery estimations. Transfusion 1989:29:703-7.
21. Szymanski IO, Valeri CR. Automated differential agglutination technic to measure red cell survival. II. Survival in vivo of preserved red cells. Transfusion 1968;8:74-83.
22. Szymanski IO, Valeri CR. Factors influencing chromium elution from labeled red cells in vivo and the effect of elution on red-cell survival measurements. Br J Haematol 1970;19:397-409.
23. Szymanski IO, Valeri CR. Lifespan of preserved red cells. Vox Sang 1971;21:97-108.
24. Chanarin I, ed. Laboratory haematology: an account of laboratory techniques. Edinburgh: Churchill Livingstone, 1989:94-6.
25. Moroff G, Sohmer PR, Button LN. Proposed standardization of methods for determining the 24-hour survival of stored red cells. Transfusion 1984;24:109-14.
26. Davey RJ. Red cell radiolabeling in transfusion medicine. In: Davey RJ, Wallace ME, eds. Diagnostic and investigational uses of radiolabeled blood elements. Arlington: American Association of Blood Banks, 1987:39-66.
27. Mollison PL, Engelfriet CP, Contreras M, eds. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell, 1993:377-94.
28. Weinstein R, Sowemimo-Coker SO, Goodrich RP. Survival of lyophilized and reconstituted human red blood cells in vivo. Transfus Clin Biol 1995;2:427-32.
29. Fairbanks G, Steck TL, Wallach DF. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971;10:2606-17.
30. Card RT, Mohandas N, Mollison PL. Relationship of posttransfusion viability to deformability of stored red cells. Br J Haematol 1983;53:237-40.
31. Wolfe L. The red cell membrane and the storage lesion. Clin Haematol 1985;14:259-76.
32. Egelund Christensen B. Effects of an enlarged splenic erythrocyte pool in chronic lymphocytic leukaemia. Mechanism of erythrocyte sequestration in the spleen and liver. Scand J Haematol 1971;8:92-103.
33. Dacie JV, Mollison PL. Survival of normal erythrocytes after transfusion to patients with familial haemolytic anaemia (acholuric jaundice). Lancet 1943;1:550-2.
34. Godal HC, Refsum HE. Haemolysis in athletes due to hereditary spherocytosis. Scand J Haematol 1979;22:83-6.